Sphera Funds Management Ltd. Inozyme Pharma, Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

A detailed history of Sphera Funds Management Ltd. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,191,140 shares of INZY stock, worth $3.49 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

1,191,140

Previous 1,462,724 18.57%

Holding current value

$3.49 Million

Previous $6.52 Million 4.51%

% of portfolio

1.14%

Previous 0.95%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.31 - $6.0 $1.17 Million - $1.63 Million	-271,584 Reduced 18.57%	1,191,140 $6.23 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $7.31 $388,907 - $656,562	89,817 Added 6.54%	1,462,724 $6.52 Million
Q1 2024 May 15, 2024	SELL	$4.14 - $7.66 $786,599 - $1.46 Million	-190,000 Reduced 12.16%	1,372,907 $10.5 Million
Q4 2023 Feb 14, 2024	BUY	$2.71 - $4.5 $888,880 - $1.48 Million	328,000 Added 26.56%	1,562,907 $6.66 Million
Q3 2023 Nov 14, 2023	BUY	$4.09 - $7.0 $421,024 - $720,580	102,940 Added 9.09%	1,234,907 $5.19 Million
Q2 2023 Aug 14, 2023	SELL	$4.93 - $6.74 $3.2 Million - $4.38 Million	-649,891 Reduced 36.47%	1,131,967 $6.31 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $203,840 - $898,464	156,800 Added 9.65%	1,781,858 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$1.05 - $2.82 $472,500 - $1.27 Million	450,000 Added 38.3%	1,625,058 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$2.57 - $5.45 $24,307 - $51,546	9,458 Added 0.81%	1,175,058 $3.15 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.96 $3.73 Million - $6.95 Million	1,165,600 New	1,165,600 $5.56 Million
Q4 2020 Feb 16, 2021	SELL	$19.95 - $27.55 $3.92 Million - $5.41 Million	-196,411 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$17.54 - $30.2 $3.45 Million - $5.93 Million	196,411 New	196,411 $5.16 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

53M

Call Options Held

3.7K

Put Options Held

5.8K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $118M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Inozyme Pharma, Inc. Transaction History